82 FR 61309 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 247 (December 27, 2017)

Page Range		61309-61310
FR Document		2017-27939
Federal Register, Volume 82 Issue 247 (Wednesday, December 27, 2017)
[Federal Register Volume 82, Number 247 (Wednesday, December 27, 2017)]
[Notices]
[Pages 61309-61310]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-27939]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant and/or contract proposals applications 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE II Review.
    Date: January 29-30, 2018.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Cachexia Therapy and Local Delivery of Chemopreventive 
Agents.
    Date: February 8, 2018.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-6: Modified RNA and Oncosomes.
    Date: February 14, 2018.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project I.
    Date: February 20-21, 2018.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Imaging Radiation and Immunotherapies.
    Date: February 20-21, 2018.
    Time: 6:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Biological Comparisons in Patient-Derived Models of Cancer.
    Date: February 23, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert S. Coyne, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W236, Bethesda, MD 20892-9750, 240-276-5120, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-2: Software Tools & Sensors for the Cancer Therapeutics.
    Date: February 28-March 1, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville 
Pike, Bethesda, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1 for Provocative Questions.
    Date: March 1, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609, Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational Exploratory/Developmental 
Studies.
    Date: March 1-2, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-1A.
    Date: March 29, 2018.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W260, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities National, Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399,

[[Page 61310]]

Cancer Control, National Institutes of Health, HHS)

    Dated: December 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27939 Filed 12-26-17; 8:45 am]
 BILLING CODE 4140-01-P
Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices 61309

Dated: December 20, 2017. Name of Committee: National Cancer Date: February 28–March 1, 2018.
Melanie J. Pantoja, Institute Special Emphasis Panel; TEP–6: Time: 5:00 p.m. to 5:00 p.m.
Modified RNA and Oncosomes. Agenda: To review and evaluate contract
Program Analyst, Office of Federal Advisory
Date: February 14, 2018. proposals.
Committee Policy.
Time: 9:00 a.m. to 6:00 p.m. Place: Hilton Washington DC/Rockville
[FR Doc. 2017–27937 Filed 12–26–17; 8:45 am] Agenda: To review and evaluate contract Hotel, 1750 Rockville Pike, Bethesda, MD
BILLING CODE 4140–01–P proposals. 20852.
Place: National Cancer Institute, Shady Contact Person: Nadeem Khan, Ph.D.,
Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Research
DEPARTMENT OF HEALTH AND 7W114, Rockville, MD 20850 (Telephone Technology and Contract Review Branch,
HUMAN SERVICES Conference Call). Division of Extramural Activities, National
Contact Person: Jeffrey E. DeClue, Ph.D., Cancer Institute, NIH 9609 Medical Center
National Institutes of Health Scientific Review Officer, Research Drive, Room 7W260, Bethesda, MD 20892–
Technology and Contract Review Branch, 9750, 240–276–5856, nadeem.khan@nih.gov.
National Cancer Institute; Notice of Division of Extramural Activities, National Name of Committee: National Cancer
Cancer Institute, NIH, 9609 Medical Center Institute Special Emphasis Panel; SEP–1 for
Closed Meetings
Drive, Room 7W114, Bethesda, MD 20892– Provocative Questions.
9750, 240–276–6371, decluej@mail.nih.gov. Date: March 1, 2018.
Pursuant to section 10(d) of the
Name of Committee: National Cancer Time: 8:00 a.m. to 5:00 p.m.
Federal Advisory Committee Act, as
Institute Special Emphasis Panel; NCI Agenda: To review and evaluate grant
amended, notice is hereby given of the Program Project I. applications.
following meetings. Date: February 20–21, 2018. Place: Gaithersburg Marriott
The meetings will be closed to the Time: 4:00 p.m. to 5:00 p.m. Washingtonian Center, 9751 Washingtonian
public in accordance with the Agenda: To review and evaluate grant Boulevard, Gaithersburg, MD 20878.
provisions set forth in sections applications. Contact Person: Byeong-Chel Lee, Ph.D.,
Place: Gaithersburg Marriott Scientific Review Officer, Resources and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Washingtonian Center, 9751 Washingtonian Training Review Branch, Division of
as amended. The grant and/or contract Boulevard, Gaithersburg, MD 20878. Extramural Activities, National Cancer
proposals applications and the Contact Person: Klaus B. Piontek, Ph.D., Institute, NIH 9609, Medical Center Drive,
discussions could disclose confidential Scientific Review Officer, Research Program Room 7W238, Bethesda, MD 20892–9750,
trade secrets or commercial property Review Branch, Division of Extramural 240–276–7755, byeong-chel.lee@nih.gov.
such as patentable material, and Activities, National Cancer Institute, NIH, Name of Committee: National Cancer
personal information concerning 9609 Medical Center Drive, Room 7W612, Institute Special Emphasis Panel, NCI
individuals associated with the grant Bethesda, MD 20892–9750, 240–276–5413. Clinical and Translational Exploratory/
and/or contract proposals applications, klaus.piontek@nih.gov. Developmental Studies.
the disclosure of which would Name of Committee: National Cancer Date: March 1–2, 2018.
constitute a clearly unwarranted Institute Special Emphasis Panel; Imaging Time: 5:00 p.m. to 5:00 p.m.
Radiation and Immunotherapies. Agenda: To review and evaluate grant
invasion of personal privacy.
Date: February 20–21, 2018. applications.
Name of Committee: National Cancer Time: 6:00 p.m. to 5:00 p.m. Place: Bethesda North Marriott Hotel &
Institute Special Emphasis Panel; NCI SPORE Agenda: To review and evaluate contract Conference Center, 5701 Marinelli Road,
II Review. proposals. North Bethesda, MD 20852.
Date: January 29–30, 2018. Place: Bethesda North Marriott Hotel & Contact Person: Zhiqiang Zou, MD, Ph.D.,
Time: 4:00 p.m. to 5:00 p.m. Conference Center, 5701 Marinelli Road, Scientific Review Officer, Special Review
Agenda: To review and evaluate grant North Bethesda, MD 20852. Branch, Division of Extramural Activities,
applications. Contact Person: Jun Fang, Ph.D., Scientific National Cancer Institute, NIH, 9609 Medical
Place: Bethesda North Marriott Hotel & Review Officer, Research Technology and Center Drive, Room 7W242, Bethesda, MD
Conference Center, 5701 Marinelli Road, Contract Review Branch, Division of 20892–9750, 240–276–6372, zouzhiq@
Bethesda, MD 20852. Extramural Activities, National Cancer mail.nih.gov.
Contact Person: Klaus B. Piontek, Ph.D., Institute, NIH, 9609 Medical Center Drive, Name of Committee: National Cancer
Scientific Review Officer, Research Program Room 7W246, Bethesda, MD 20892–9750, Institute Special Emphasis Panel; NCI R03 &
Review Branch, Division of Extramural 240–276–5460, jfang@mail.nih.gov. Clinical and Translational R21: SEP–1A.
Activities, National Cancer Institute, NIH, Name of Committee: National Cancer Date: March 29, 2018.
9609 Medical Center Drive, Room 7W612, Institute Special Emphasis Panel; Biological Time: 11:00 a.m. to 4:00 p.m.
Bethesda, MD 20892–9750, 240–276–5413, Comparisons in Patient-Derived Models of Agenda: To review and evaluate grant
klaus.piontek@nih.gov. Cancer. applications.
Name of Committee: National Cancer Date: February 23, 2018. Place: National Cancer Institute, Shady
Institute Special Emphasis Panel; Cancer Time: 1:00 p.m. to 4:00 p.m. Grove, 9609 Medical Center Drive, Room
Cachexia Therapy and Local Delivery of Agenda: To review and evaluate grant 7W260, Rockville, MD 20850 (Telephone
Chemopreventive Agents. applications. Conference Call).
Date: February 8, 2018. Place: National Cancer Institute, Shady Contact Person: Nadeem Khan, Ph.D.,
Time: 9:00 a.m. to 4:00 p.m. Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Research
Agenda: To review and evaluate contract 7W236, Rockville, MD 20850 (Telephone Technology and Contract Review Branch,
proposals. Conference Call). Division of Extramural Activities National,
Place: National Cancer Institute, Shady Contact Person: Robert S. Coyne, Ph.D., Cancer Institute, NIH, 9609 Medical Center
Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Special Review Drive, Room 7W260, Bethesda, MD 20892–
7W030, Rockville, MD 20850 (Telephone Branch, Division of Extramural Activities, 9750, 240–276–5856, nadeem.khan@nih.gov.
daltland on DSKBBV9HB2PROD with NOTICES

Conference Call). National Cancer Institute, NIH, 9609 Medical (Catalogue of Federal Domestic Assistance
Contact Person: Jun Fang, Ph.D., Scientific Center Drive, Room 7W236, Bethesda, MD Program Nos. 93.392, Cancer Construction;
Review Officer, Research Technology and 20892–9750, 240–276–5120, coynes@ 93.393, Cancer Cause and Prevention
Contract Review Branch, Division of mail.nih.gov. Research; 93.394, Cancer Detection and
Extramural Activities, National Cancer Name of Committee: National Cancer Diagnosis Research; 93.395, Cancer
Institute, NIH, 9609 Medical Center Drive, Institute Special Emphasis Panel; TEP–2: Treatment Research; 93.396, Cancer Biology
Room 7W246, Bethesda, MD 20892–9750, Software Tools & Sensors for the Cancer Research; 93.397, Cancer Centers Support;
240–276–5460, jfang@mail.nih.gov. Therapeutics. 93.398, Cancer Research Manpower; 93.399,

VerDate Sep<11>2014 21:43 Dec 26, 2017 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\27DEN1.SGM 27DEN1
61310 Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices

Cancer Control, National Institutes of Health, Lane, MSC 9823, Bethesda, MD 20892–9823, SUPPLEMENTARY INFORMATION: The
HHS) 240) 669–5044, nv19q@nih.gov. Commercial Fishing Safety Advisory
Dated: December 20, 2017. (Catalogue of Federal Domestic Assistance Committee is a federal advisory
Melanie J. Pantoja, Program Nos. 93.855, Allergy, Immunology, committee which operates under the
and Transplantation Research; 93.856, provisions of the Federal Advisory
Program Analyst, Office of Federal Advisory Microbiology and Infectious Diseases
Committee Policy. Committee Act, (Title 5, U.S.C.
Research, National Institutes of Health, HHS)
[FR Doc. 2017–27939 Filed 12–26–17; 8:45 am] Appendix). The U.S. Coast Guard
Dated: December 21, 2017. chartered the Commercial Fishing
BILLING CODE 4140–01–P
Natasha M. Copeland, Safety Advisory Committee to provide
Program Analyst, Office of Federal Advisory advice on issues related to the safety of
DEPARTMENT OF HEALTH AND Committee Policy. commercial fishing industry vessels
HUMAN SERVICES [FR Doc. 2017–27938 Filed 12–26–17; 8:45 am] regulated under Chapter 45 of title 46,
BILLING CODE 4140–01–P United States Code, which includes
National Institutes of Health uninspected fish catching vessels, fish
processing vessels, and fish tender
National Institute of Allergy and DEPARTMENT OF HOMELAND vessels. (See Title 46 U.S.C. 4508.)
Infectious Diseases; Notice of Closed SECURITY The Commercial Fishing Safety
Meetings Advisory Committee meets at least once
Coast Guard a year. It may also meet for other
Pursuant to section 10(d) of the
extraordinary purposes. Its
Federal Advisory Committee Act, as [Docket No. USCG–2017–1009] subcommittees or working groups may
amended, notice is hereby given of the communicate throughout the year to
following meetings. Commercial Fishing Safety Advisory
prepare for meetings or develop
The meetings will be closed to the Committee
proposals for the committee as a whole
public in accordance with the
AGENCY: U.S. Coast Guard, Department or to address specific tasks.
provisions set forth in sections Each member serves for a term of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., of Homeland Security.
ACTION: Request for applications.
three years. An individual may be
as amended. The grant applications and appointed to a term as a member more
the discussions could disclose than once, but not more than two terms
SUMMARY: The U.S. Coast Guard seeks
confidential trade secrets or commercial consecutively. All members serve at
applications for membership on the
property such as patentable material, their own expense and receive no salary
Commercial Fishing Safety Advisory
and personal information concerning or other compensation from the Federal
Committee. The Commercial Fishing
individuals associated with the grant Government, although travel
Safety Advisory Committee provides
applications, the disclosure of which reimbursement and per diem may be
advice and makes recommendations to
would constitute a clearly unwarranted provided for called meetings.
the Coast Guard and the Department of
invasion of personal privacy. The U.S. Coast Guard will consider
Homeland Security on various matters
Name of Committee: National Institute of relating to the safe operation of applications for two (02) positions that
Allergy and Infectious Diseases Special commercial fishing industry vessels. will be vacant on January 2018 in the
Emphasis Panel; Partnerships for Both positions were previously following categories:
Development of Clinically Useful Diagnostics (a) An individual who represents the
for Antimicrobial-Resistant Bacteria (R01).
advertised under Docket No. USCG–
2017–0829 but no applications for either general public, a marine surveyor who
Date: January 18, 2018. provides services to vessels to which
Time: 11:00 a.m. to 5:00 p.m. of the two positions were received.
Agenda: To review and evaluate grant
Chapter 45 of Title 46 U.S.C. applies
DATES: Completed applications should
applications. (one position);
be submitted to the U.S. Coast Guard on (b) An individual who represents
Place: National Institutes of Health, 5601 or before February 26, 2018.
Fishers Lane, Rockville, MD 20892 manufacturers of equipment for vessels
(Telephone Conference Call). ADDRESSES: Applicants should send a to which Chapter 45 of Title 46, U.S.C.
Contact Person: Lynn Rust, Ph.D., cover letter expressing interest in an applies (one position);
Scientific Review Officer, Scientific Review appointment to the Commercial Fishing If you are selected as a member from
Program, Division of Extramural Activities, Safety Advisory Committee that also the general public, you will be
room 3G42A, National Institutes of Health/ identifies which membership category appointed and serve as a Special
NIAID, 5601 Fishers Lane, MSC 9823, the applicant is applying under, along Government Employee as defined in
Bethesda, MD 20892–9823, (240) 669–5069, with a resume detailing the applicant’s Section 202(a) of Title 18, U.S.C.
lrust@niaid.nih.gov. experience via one of the following Applicants for appointment as a Special
Name of Committee: National Institute of methods: Government Employee are required to
Allergy and Infectious Diseases Special • By Email: Jonathan.G.Wendland@
Emphasis Panel; NIAID Clinical Trial
complete a Confidential Financial
uscg.mil, Subject line: The Commercial Disclosure Report (OGE Form 450). The
Implementation Cooperative Agreement
(U01). Fishing Safety Advisory Committee. U.S. Coast Guard may not release the
Date: January 19, 2018. • By Mail: Commandant (CG–CVC– reports or the information in them to the
Time: 10:00 a.m. to 1:00 p.m. 3)/CFSAC, Attn: Mr. Jonathan public except under an order issued by
Agenda: To review and evaluate grant Wendland, U.S. Coast Guard, 2703 a Federal court or as otherwise provided
applications. Martin Luther King Ave. SE, Stop 7501, under the Privacy Act (5 U.S.C. 552a).
daltland on DSKBBV9HB2PROD with NOTICES

Place: National Institutes of Health 5601 Washington, DC 20593–7501. Only the Designated U.S. Coast Guard
Fishers Lane, Rockville, MD 20892 Ethics Official or his or her designee
FOR FURTHER INFORMATION CONTACT: Mr.
(Telephone Conference Call).
Contact Person: Nancy Vazquez-
Jonathan Wendland, Alternate may release a Confidential Financial
Maldonado, Ph.D., Scientific Review Officer, Designated Federal Officer of the Disclosure Report. Applicants can
Scientific Review Program, Division of Commercial Fishing Safety Advisory obtain this form by going to the website
Extramural Activities, Room 3F52B National Committee, 202–372–1245 or of the Office of Government Ethics
Institutes of Health/NIAID, 5601 Fishers Jonathan.G.Wendland@uscg.mil. (www.oge.gov), or by contacting the

VerDate Sep<11>2014 21:43 Dec 26, 2017 Jkt 244001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\27DEN1.SGM 27DEN1
Document Created: 2017-12-27 02:23:57
Document Modified: 2017-12-27 02:23:57
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 29-30, 2018.
FR Citation		82 FR 61309